The dream and reality of histology agnostic cancer clinical trials

od Lacombe, Denis, Burock, Susen, Bogaerts, Jan, Schoeffski, Patrick, Golfinopoulos, Vassilis, Stupp, Roger
Izdano u Mol Oncol (2014)

Evaluation of Alternate Categorical Tumor Metrics and Cut Points for Response Categorization Using the RECIST 1.1 Data Warehouse

od Mandrekar, Sumithra J., An, Ming-Wen, Meyers, Jeffrey, Grothey, Axel, Bogaerts, Jan, Sargent, Daniel J.
Izdano 2014

Late translational research: putting forward a new model for developing new anti‐cancer treatments that addresses the needs of patients and society

od Lacombe, Denis, Bogaerts, Jan, Tombal, Bertrand, Maignen, François, Osipienko, Leeza, Sullivan, Richard, Golfinopoulos, Vassilis
Izdano u Mol Oncol (2019)

Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods

od An, Ming-Wen, Han, Yu, Meyers, Jeffrey P., Bogaerts, Jan, Sargent, Daniel J., Mandrekar, Sumithra J.
Izdano u J Clin Oncol (2015)

Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival

od An, Ming-Wen, Dong, Xinxin, Meyers, Jeffrey, Han, Yu, Grothey, Axel, Bogaerts, Jan, Sargent, Daniel J., Mandrekar, Sumithra J.
Izdano u J Natl Cancer Inst (2015)

Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and...

od Paridaens, Robert J., Dirix, Luc Y., Beex, Louk V., Nooij, Marianne, Cameron, David A., Cufer, Tanja, Piccart, Martine J., Bogaerts, Jan, Therasse, Patrick
Izdano 2008

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules

od Dafni, Urania, Karlis, Dimitris, Pedeli, Xanthi, Bogaerts, Jan, Pentheroudakis, George, Tabernero, Josep, Zielinski, Christoph C, Piccart, Martine J, de Vries, Elisabeth G E, Latino, Nicola Jane, Douillard, Jean-Yves, Cherny, Nathan I
Izdano u ESMO Open (2017)

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral het...

od Viale, Giuseppe, Slaets, Leen, de Snoo, Femke A., Bogaerts, Jan, Russo, Leila, van’t Veer, Laura, Rutgers, Emiel J. T., Piccart-Gebhart, Martine J., Stork-Sloots, Lisette, Dell’Orto, Patrizia, Glas, Annuska M., Cardoso, Fatima
Izdano u Breast Cancer Res Treat (2016)

RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis

od Litière, Saskia, Isaac, Gaëlle, De Vries, Elisabeth G.E., Bogaerts, Jan, Chen, Alice, Dancey, Janet, Ford, Robert, Gwyther, Stephen, Hoekstra, Otto, Huang, Erich, Lin, Nancy, Liu, Yan, Mandrekar, Sumithra, Schwartz, Lawrence H., Shankar, Lalitha, Therasse, Patrick, Seymour, Lesley
Izdano u J Clin Oncol (2019)

Role of Axillary Clearance After a Tumor-Positive Sentinel Node in the Administration of Adjuvant Therapy in Early Breast Cancer

od Straver, Marieke E., Meijnen, Philip, van Tienhoven, Geertjan, van de Velde, Cornelis J.H., Mansel, Robert E., Bogaerts, Jan, Demonty, Gaston, Duez, Nicole, Cataliotti, Luigi, Klinkenbijl, Jean, Westenberg, Helen A., van der Mijle, Huub, Hurkmans, Coen, Rutgers, Emiel J.T.
Izdano 2010

Sentinel Node Identification Rate and Nodal Involvement in the EORTC 10981-22023 AMAROS Trial

od Straver, Marieke E., Meijnen, Philip, van Tienhoven, Geertjan, van de Velde, Cornelis J. H., Mansel, Robert E., Bogaerts, Jan, Duez, Nicole, Cataliotti, Luigi, Klinkenbijl, Jean H. G., Westenberg, Helen A., van der Mijle, Huub, Snoj, Marko, Hurkmans, Coen, Rutgers, Emiel J. T.
Izdano 2010

RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group

od Schwartz, Lawrence H., Seymour, Lesley, Litière, Saskia, Ford, Robert, Gwyther, Stephen, Mandrekar, Sumithra, Shankar, Lalitha, Bogaerts, Jan, Chen, Alice, Dancey, Janet, Hayes, Wendy, Hodi, F. Stephen, Hoekstra, Otto S., Huang, Erich P., Lin, Nancy, Liu, Yan, Therasse, Patrick, Wolchok, Jedd D., de Vries, Elisabeth
Izdano u Eur J Cancer (2016)

RECIST 1.1 – Update and Clarification: From the RECIST Committee

od Schwartz, Lawrence H., Litière, Saskia, de Vries, Elisabeth, Ford, Robert, Gwyther, Stephen, Mandrekar, Sumithra, Shankar, Lalitha, Bogaerts, Jan, Chen, Alice, Dancey, Janet, Hayes, Wendy, Hodi, F. Stephen, Hoekstra, Otto S., Huang, Erich P., Lin, Nancy, Liu, Yan, Therasse, Patrick, Wolchok, Jedd D., Seymour, Lesley
Izdano u Eur J Cancer (2016)

Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial

od Jacob, Laurent, Witteveen, Anke, Beumer, Inès, Delahaye, Leonie, Wehkamp, Diederik, van den Akker, Jeroen, Snel, Mireille, Chan, Bob, Floore, Arno, Bakx, Niels, Brink, Guido, Poncet, Coralie, Bogaerts, Jan, Delorenzi, Mauro, Piccart, Martine, Rutgers, Emiel, Cardoso, Fatima, Speed, Terence, van ’t Veer, Laura, Glas, Annuska
Izdano u Commun Biol (2020)

Phase III trial (EORTC 10994/BIG 1-00) assessing the value of p53 using a functional assay to predict sensitivity to a taxane versus non taxane primary chemotherapy in breast cance...

od Bonnefoi, Hervé, Piccart, Martine, Bogaerts, Jan, Mauriac, Louis, Fumoleau, Pierre, Brain, Etienne, Petit, Thierry, Rouanet, Philippe, Jassem, Jacek, Blot, Emmanuel, Zaman, Khalil, Cufer, Tanja, Lortholary, Alain, Lidbrink, Elisabet, André, Sylvie, Litière, Saskia, Lago, Lissandra Dal, Becette, Véronique, Cameron, David A., Bergh, Jonas, Iggo, Richard
Izdano 2011

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

od Seymour, Lesley, Bogaerts, Jan, Perrone, Andrea, Ford, Robert, Schwartz, Lawrence H, Mandrekar, Sumithra, Lin, Nancy U, Litière, Saskia, Dancey, Janet, Chen, Alice, Hodi, F Stephen, Therasse, Patrick, Hoekstra, Otto S, Shankar, Lalitha K, Wolchok, Jedd D, Ballinger, Marcus, Caramella, Caroline, de Vries, Elisabeth G E
Izdano u Lancet Oncol (2017)

Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial

od Delaloge, Suzette, Piccart, Martine, Rutgers, Emiel, Litière, Saskia, van ’t Veer, Laura J., van den Berkmortel, Franchette, Brain, Etienne, Dudek-Peric, Aleksandra, Gil-Gil, Miguel, Gomez, Patricia, Hilbers, Florentine S., Khalil, Zaman, Knox, Susan, Kuemmel, Sherko, Kunz, Georg, Lesur, Anne, Pierga, Jean-Yves, Ravdin, Peter, Rubio, Isabel T., Saghatchian, Mahasti, Smilde, Tineke J., Thompson, Alastair M., Viale, Giuseppe, Zoppoli, Gabriele, Vuylsteke, Peter, Tryfonidis, Konstantinos, Poncet, Coralie, Bogaerts, Jan, Cardoso, Fatima
Izdano u J Clin Oncol (2020)

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS):a randomised, multicentre, open-label, phase 3 non-inferiority tria...

od Donker, Mila, van Tienhoven, Geertjan, Straver, Marieke E, Meijnen, Philip, van de Velde, Cornelis J H, Mansel, Robert E, Cataliotti, Luigi, Westenberg, A Helen, Klinkenbijl, Jean H G, Orzalesi, Lorenzo, Bouma, Willem H, van der Mijle, Huub C J, Nieuwenhuijzen, Grard A P, Veltkamp, Sanne C, Slaets, Leen, Duez, Nicole J, de Graaf, Peter W, van Dalen, Thijs, Marinelli, Andreas, Rijna, Herman, Snoj, Marko, Bundred, Nigel J, Merkus, Jos W S, Belkacemi, Yazid, Petignat, Patrick, Schinagl, Dominic A X, Coens, Corneel, Messina, Carlo G M, Bogaerts, Jan, Rutgers, Emiel J T
Izdano u Lancet Oncol (2014)

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

od Bogaerts, Jan, Sydes, Matthew R., Keat, Nicola, McConnell, Andrea, Benson, Al, Ho, Alan, Roth, Arnaud, Fortpied, Catherine, Eng, Cathy, Peckitt, Clare, Coens, Corneel, Pettaway, Curtis, Arnold, Dirk, Hall, Emma, Marshall, Ernie, Sclafani, Francesco, Hatcher, Helen, Earl, Helena, Ray-Coquard, Isabelle, Paul, James, Blay, Jean-Yves, Whelan, Jeremy, Panageas, Kathy, Wheatley, Keith, Harrington, Kevin, Licitra, Lisa, Billingham, Lucinda, Hensley, Martee, McCabe, Martin, Patel, Poulam M., Carvajal, Richard, Wilson, Richard, Glynne-Jones, Rob, McWilliams, Rob, Leyvraz, Serge, Rao, Sheela, Nicholson, Steve, Filiaci, Virginia, Negrouk, Anastassia, Lacombe, Denis, Dupont, Elisabeth, Pauporté, Iris, Welch, John J., Law, Kate, Trimble, Ted, Seymour, Matthew
Izdano u Eur J Cancer (2015)

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

od Dittrich, Christian, Kosty, Michael, Jezdic, Svetlana, Pyle, Doug, Berardi, Rossana, Bergh, Jonas, El-Saghir, Nagi, Lotz, Jean-Pierre, Österlund, Pia, Pavlidis, Nicholas, Purkalne, Gunta, Awada, Ahmad, Banerjee, Susana, Bhatia, Smita, Bogaerts, Jan, Buckner, Jan, Cardoso, Fatima, Casali, Paolo, Chu, Edward, Close, Julia Lee, Coiffier, Bertrand, Connolly, Roisin, Coupland, Sarah, De Petris, Luigi, De Santis, Maria, de Vries, Elisabeth G E, Dizon, Don S, Duff, Jennifer, Duska, Linda R, Eniu, Alexandru, Ernstoff, Marc, Felip, Enriqueta, Fey, Martin F, Gilbert, Jill, Girard, Nicolas, Glaudemans, Andor W J M, Gopalan, Priya K, Grothey, Axel, Hahn, Stephen M, Hanna, Diana, Herold, Christian, Herrstedt, Jørn, Homicsko, Krisztian, Jones, Dennie V, Jost, Lorenz, Keilholz, Ulrich, Khan, Saad, Kiss, Alexander, Köhne, Claus-Henning, Kunstfeld, Rainer, Lenz, Heinz-Josef, Lichtman, Stuart, Licitra, Lisa, Lion, Thomas, Litière, Saskia, Liu, Lifang, Loehrer, Patrick J, Markham, Merry Jennifer, Markman, Ben, Mayerhoefer, Marius, Meran, Johannes G, Michielin, Olivier, Moser, Elizabeth Charlotte, Mountzios, Giannis, Moynihan, Timothy, Nielsen, Torsten, Ohe, Yuichiro, Öberg, Kjell, Palumbo, Antonio, Peccatori, Fedro Alessandro, Pfeilstöcker, Michael, Raut, Chandrajit, Remick, Scot C, Robson, Mark, Rutkowski, Piotr, Salgado, Roberto, Schapira, Lidia, Schernhammer, Eva, Schlumberger, Martin, Schmoll, Hans-Joachim, Schnipper, Lowell, Sessa, Cristiana, Shapiro, Charles L, Steele, Julie, Sternberg, Cora N, Stiefel, Friedrich, Strasser, Florian, Stupp, Roger, Sullivan, Richard, Tabernero, Josep, Travado, Luzia, Verheij, Marcel, Voest, Emile, Vokes, Everett, Von Roenn, Jamie, Weber, Jeffrey S, Wildiers, Hans, Yarden, Yosef
Izdano u ESMO Open (2016)